Ryvu Therapeutics Investor Relations Material

Ryvu Therapeutics S.A. is a Poland-based biotechnology company focused on the research and development of novel small molecule therapies. The company specializes in discovering and developing treatments for cancer, particularly in the areas of targeted therapies and immuno-oncology. Ryvu conducts both early-stage discovery and clinical development activities, with a pipeline supported by internal research capabilities and collaborative partnerships. The company is headquartered in Kraków, Poland, and its shares are listed on the WSE.